WHO hails SA's rollout of Lenacapavir as major global milestone

The World Health Organization has commended South Africa for becoming one of the first nations to implement a national rollout of Lenacapavir, a long-acting HIV prevention drug. The twice-yearly injectable is considered a major breakthrough in global HIV prevention efforts.
Why it matters
This rollout represents a significant advancement in public health technology and HIV management strategies.
Updated June 19, 2026, 12:13 p.m. | By Mmangaliso Khumalo
Reports on public health milestones with a focus on international institutional praise.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in